Saturday, February 21, 2026
ISSN 2765-8767
  • Survey
  • Podcast
  • Write for Us
  • My Account
  • Log In
Daily Remedy
  • Home
  • Articles
  • Podcasts
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    July 1, 2025

    The cost structure of hospitals nearly doubles

    July 1, 2025
    Navigating the Medical Licensing Maze

    The Fight Against Healthcare Fraud: Dr. Rafai’s Story

    April 8, 2025
  • Surveys

    Surveys

    How Confident Are You in RFK Jr.’s Health Leadership?

    How Confident Are You in RFK Jr.’s Health Leadership?

    February 16, 2026
    AI in Healthcare Decision-Making

    AI in Healthcare Decision-Making

    February 1, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
  • Home
  • Articles
  • Podcasts
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    July 1, 2025

    The cost structure of hospitals nearly doubles

    July 1, 2025
    Navigating the Medical Licensing Maze

    The Fight Against Healthcare Fraud: Dr. Rafai’s Story

    April 8, 2025
  • Surveys

    Surveys

    How Confident Are You in RFK Jr.’s Health Leadership?

    How Confident Are You in RFK Jr.’s Health Leadership?

    February 16, 2026
    AI in Healthcare Decision-Making

    AI in Healthcare Decision-Making

    February 1, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
Daily Remedy
No Result
View All Result
Home Trends

The Midlife Market: How Menopause Care Finally Went Mainstream

From celebrity-backed brands to big-box beauty retailers, menopause is being rebranded as a visible, viable part of women's health—and commerce.

Ashley Rodgers by Ashley Rodgers
May 6, 2025
in Trends
0

In the quiet margins of healthcare, menopause has long stood as a gaping omission. A ubiquitous biological transition that affects over one billion women globally, menopause has been routinely treated more as a private affliction than a public health concern. But in recent years, that narrative is shifting—and dramatically so. The once-hushed vocabulary of hot flashes, night sweats, and hormone fluctuations is now being uttered across podcasts, Instagram reels, beauty counters, and venture-backed startups.

From Michelle Obama’s podcast reflections on the disorienting experience of menopause to Naomi Watts’ launch of Stripes, a brand dedicated to midlife women’s wellness, celebrities are not just talking about menopause—they’re building platforms around it. In Watts’ words, Stripes is about “amplifying a conversation that has been stifled by stigma,” a sentiment echoed by Halle Berry, who co-founded Respin Health, a holistic wellness platform inclusive of menopause-specific resources.

This celebrity-fronted movement is dovetailing with a broader commercialization of midlife wellness. Retail giants like Sephora and Ulta Beauty—once synonymous with youth-obsessed beauty culture—are now investing in shelf space for menopause-related products. Items such as estrogen-free moisturizers, hot flash cooling sprays, and sleep supplements are no longer tucked away in the corners of pharmacies; instead, they are merchandised under curated “Wellness for Every Stage” banners.

What we are witnessing is not simply a rebranding of menopause, but its strategic repositioning in the cultural and commercial mainstream. According to data from Grand View Research, the global menopause market was valued at $15.4 billion in 2021 and is projected to grow at a compound annual growth rate (CAGR) of 5.7% through 2030. This isn’t a passing trend; it’s a structural shift.

Yet the roots of this shift are as much sociocultural as they are economic. The average American woman reaches menopause at age 51—at the peak of her career and productivity. And with the U.S. Census Bureau projecting that by 2030, women aged 45 to 64 will make up nearly 25% of the adult female population, the stakes for better care, policy, and products are rising.

Despite this demographic shift, healthcare has lagged. A 2023 survey by the Mayo Clinic found that only 31% of women felt their healthcare providers were well-informed about menopause. Even among OB-GYNs, fewer than one in five residency programs in the United States include formal menopause training, according to the American College of Obstetricians and Gynecologists.

“The silence around menopause isn’t just social—it’s systemic,” explains Dr. Sharon Malone, a board-certified OB-GYN and menopause specialist. “We’ve treated it as a side effect of aging rather than a major health transition deserving of serious medical attention.”

This silence is now being broken by a new wave of femtech startups, social media communities, and policy advocates. While celebrity voices help destigmatize, it’s the convergence with scientific advocacy and consumer demand that gives this moment its momentum. Organizations like The Menopause Society (formerly the North American Menopause Society) are working to raise clinical standards and public awareness, while platforms like Gennev and Elektra Health offer telehealth services explicitly for menopause management.

But the movement also raises questions: Will this cultural pivot translate into better clinical outcomes? Or will menopause, like other aspects of women’s health, become commodified without improving equity or access?

Critics caution against what they see as the wellness-industrial complex wrapping midlife distress in aspirational packaging. “The danger lies in treating menopause like a lifestyle brand,” says Dr. Jen Gunter, OB-GYN and author of The Menopause Manifesto. “The medical complexity shouldn’t be lost in the marketing.”

Still, the significance of this shift can’t be dismissed. For too long, menopause has been a health blind spot. The new visibility—whether in a Netflix special, a Sephora aisle, or a TikTok tutorial—represents a collective recalibration of how society values aging, autonomy, and care.

In that recalibration, midlife women are finding more than just moisturizers and mood-balancing teas. They’re finding legitimacy. And perhaps, at last, the promise of informed, dignified care.

ShareTweet
Ashley Rodgers

Ashley Rodgers

Ashley Rodgers is a writer specializing in health, wellness, and policy, bringing a thoughtful and evidence-based voice to critical issues.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Videos

This conversation focuses on debunking myths surrounding GLP-1 medications, particularly the misinformation about their association with pancreatic cancer. The speaker emphasizes the importance of understanding clinical study designs, especially the distinction between observational studies and randomized controlled trials. The discussion highlights the need for patients to critically evaluate the sources of information regarding medication side effects and to empower themselves in their healthcare decisions.

Takeaways
GLP-1 medications are not linked to pancreatic cancer.
Peer-reviewed studies debunk misinformation about GLP-1s.
Anecdotal evidence is not reliable for general conclusions.
Observational studies have limitations in generalizability.
Understanding study design is crucial for evaluating claims.
Symptoms should be discussed in the context of clinical conditions.
Not all side effects reported are relevant to every patient.
Observational studies can provide valuable insights but are context-specific.
Patients should critically assess the relevance of studies to their own experiences.
Engagement in discussions about specific studies can enhance understanding

Chapters
00:00
Debunking GLP-1 Medication Myths
02:56
Understanding Clinical Study Designs
05:54
The Role of Observational Studies in Healthcare
Debunking Myths About GLP-1 Medications
YouTube Video DM9Do_V6_sU
Subscribe

2027 Medicare Advantage & Part D Advance Notice

Clinical Reads

BIIB080 in Mild Alzheimer’s Disease: What a Phase 1b Exploratory Clinical Analysis Can—and Cannot—Tell Us

BIIB080 in Mild Alzheimer’s Disease: What a Phase 1b Exploratory Clinical Analysis Can—and Cannot—Tell Us

by Daily Remedy
February 15, 2026
0

Can lowering tau biology translate into a clinically meaningful slowing of decline in people with early symptomatic Alzheimer’s disease? That is the practical question behind BIIB080, an intrathecal antisense therapy designed to reduce production of tau protein by targeting the tau gene transcript. In a phase 1b program originally designed for safety and dosing, investigators later examined cognitive, functional, and global outcomes as exploratory endpoints. The clinical question matters because current disease-modifying options primarily target amyloid, while tau pathology tracks...

Read more

Join Our Newsletter!

Twitter Updates

Tweets by TheDailyRemedy

Popular

  • The Prevention Gap in Dementia Care

    The Prevention Gap in Dementia Care

    0 shares
    Share 0 Tweet 0
  • Healthcare in Space

    1 shares
    Share 0 Tweet 0
  • Healthcare Natural Rights

    0 shares
    Share 0 Tweet 0
  • Heat Safety Tips Every Pregnant Mother Should Know

    0 shares
    Share 0 Tweet 0
  • What is the 411 on the New 988 Hotline?

    0 shares
    Share 0 Tweet 0
  • 628 Followers

Daily Remedy

Daily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.

Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.

Important Links

  • Support Us
  • About Us
  • Contact us
  • Privacy Policy
  • Terms and Conditions

Join Our Newsletter!

  • Survey
  • Podcast
  • About Us
  • Contact us

© 2026 Daily Remedy

No Result
View All Result
  • Home
  • Articles
  • Podcasts
  • Surveys
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner

© 2026 Daily Remedy